{"name":"Clarametyx Biosciences, Inc.","slug":"clarametyx-biosciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxOR1F5WExTTFRxUlVWLVlBN0pvNTdRUXVoSW8yVE92NkcyRUUxN0I4Wk91bWtfSFFoUzJPa2I2R2xhUFNZWnRrdE1iaFVadWRieUhOTTZrRzA1OTdtYlFjOFVqdE1kM3VJQlhxYWJUMV9WajFXc0oxZXJyX2tYb2V4R1JTX2hmUnBpN1RZcVBkUWRYaDMtV2pUa3c4VVIwNHlpeWVPNjNiOG80SmZwbjVvQVBTUnhLUjdTRVpIMVFJSmprbGE1N05kNjV2dG9HU1NhN1NMTWlRaXJlQkIwMzkyRGJ1UmZZQzM4dktsUWVzUlQ0UGhsOUdqc1ZIM191aXlfeDlpZUhBSHJ3cGRlZVBBR2FnZmZDLU1fekFzOWR6ZUszUlBjSDRZ?oc=5","date":"2026-04-02","type":"pipeline","source":"WBOC TV","summary":"Clarametyx Biosciences Strengthens Executive Leadership to Accelerate Clinical Development Efforts - WBOC TV","headline":"Clarametyx Biosciences Strengthens Executive Leadership to Accelerate Clinical Development Efforts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxNMnBoa1pfS3FXOFFGakpEQV9lTUhVa0FzRDdoZ2N0aUFCWW1jbGRWSThfYks0eVJSdUxWSHFaR1VXMW1UOGZSRWNzSmhnMWRMQUpoSUVVZmxyRHE5TkIzOE95WThMT0dHTmtrRWw2bXB0RDBNa2swbVB6RUstUkNOUXJXV3BzUWFWeGlMNUFqdkNOWHFXV3dYbzJOTEF6czlDWkdrNGJRRjByamt6ejlZVnpsLWt5blZfUkF3bWw3cGM0R3EwS1ZPZUhKampiWFBUN1lWZ3Q1UDhOWUJxbTNCZkFtUjlBM3MxdV95aFBEbWsyMDIxdkxDczZvWkdGZzdO?oc=5","date":"2026-01-27","type":"pipeline","source":"businesswire.com","summary":"Clarametyx Biosciences Strengthens Scientific Advisory Board With Expert Appointments to Advance Pipeline Programs - businesswire.com","headline":"Clarametyx Biosciences Strengthens Scientific Advisory Board With Expert Appointments to Advance Pipeline Programs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxPc3U0SjJvSnlYblhxSUx6ZXlGeTBVNDc5M19Xc2FkWTk2VE5EYm5Gcm91M3ZRaW4xMnM4QUU5dWctYnBNc0VLeXpxX2ZvS29VWnlnZVFHbzRwc3YzblR0ejlZVG52WmdFbzkyUjBCZmJjOVo3VV9yQ21GYVhEZXJBRUl6ckh3TG9TMUdDV0hLRGU2M0NnTWlEM0ljdWVxR3FLaS1IUTR5dUczQXhOQ29WRlVkcERfOTFyRFBreE1jbGo3RUYtSGNzZnJ1QXJicjBFQUYyTVNoN29OX2hBeXhxc2V0ZHQyNUtkU3NDR002NEhXbmJqYTFkcw?oc=5","date":"2025-10-20","type":"pipeline","source":"businesswire.com","summary":"Clarametyx Biosciences Strengthens Leadership Team to Accelerate Pipeline and Corporate Development Progress - businesswire.com","headline":"Clarametyx Biosciences Strengthens Leadership Team to Accelerate Pipeline and Corporate Development Progress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxQZy1aYjBkWlViemNJN0JJX3J2VTBublF4V1lmTlBpbWJjX0xfcTQzeE1xRlFpdXRaakh4bk14Nnl6ZXozNXJrRnZUeHdVM2NSa0RwYVF3X19sOEJubTBnU3FUQk1qRE92M2pEZUdQeXRKcGZzQm5UdDFLT0M2ckR3XzRkLUZWbG9IN0l5UnVNVTNrVzRQSjcyaGZrTlJPa3hqclQtaXlRc014WEt2YTNtdzZzQzNhNTRsVDRFNTBQQmlGY3dtVGlNMW9QTmVxazduR191cF90N0g3MUI5dnlJMC1RbGFaX3VPM2xrSl9Uejd5TF96blE?oc=5","date":"2025-10-16","type":"trial","source":"businesswire.com","summary":"Clarametyx Biosciences Announces Completion of Enrollment in Phase 2a Study of CMTX-101 in Cystic Fibrosis - businesswire.com","headline":"Clarametyx Biosciences Announces Completion of Enrollment in Phase 2a Study of CMTX-101 in Cystic Fibrosis","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxPaUZfWkxrVFd0aWU1T2VtT05zTGRjU3ZpbU44U2VmbkxCajdRb1dvMVB3aEE1VzE2TmVNUzFWRjBXTHZUdllwN3lwemhLc1pIeUhFN1JKYmpiQVVWY04yZ2xqT0JvYzdiVkdFeDBSTmVyQlBFR2tYem9FR1JPVlJleUgweHlnWTJKekdYNjU2Yl9vaDdOdTdzX1V2YWt6b2VWLXFGczZIakFxa2dmdGRlQUNDdHRGZUxtbllTeDdVZzVheGxBYlB3REhtUWRGZjlOLUZwM2NqNW9lWDBseVFacjBtVy01b1ZWb2FfaDNnVnN0QWNxbFluVkUzanZNOS10WVJMN2NERlZtcVZF?oc=5","date":"2025-08-04","type":"regulatory","source":"businesswire.com","summary":"Clarametyx Biosciences Announces FDA Grant of Fast Track and Qualified Infectious Disease Product Designations for CMTX-101 - businesswire.com","headline":"Clarametyx Biosciences Announces FDA Grant of Fast Track and Qualified Infectious Disease Product Designations for CMTX-","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOdzExU3VzbEFiUWlBamxCSlY3RGw4emdveFFvQnZXV3JKcFBYSFNxLV9FMng5RnF6U1FMeDJBVkY1X2VaN3psVE5MQkc0dHdqWXppS0FoZC15YlMyWVJlSndwcXhtSE0tR1hlbXBJOFRxTHFqM2JGQzF2cjhsTmJ4U0ZtekoxbzhlOXBmVkl0NmMzV2M?oc=5","date":"2024-09-27","type":"pipeline","source":"The Business Journals","summary":"Innovators in Healthcare and Life Sciences Awards: Here are the 2024 honorees - The Business Journals","headline":"Innovators in Healthcare and Life Sciences Awards: Here are the 2024 honorees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5QQ3JKVzhLckdRem9xbHVyaTlLamo3bVBhVUwxeWMzOVNFdERaV21LR1Y2Z0VBcnV3UWR0eElUNFZFV2lOTE9JVU5wUmJvUjJ3TXFEOGppMHJjWG9kSWJ6QVB2NW1hV0Frbk1EX0J3?oc=5","date":"2024-06-04","type":"pipeline","source":"Labiotech.eu","summary":"Ohio’s finest: Eight biotech companies leading the way - Labiotech.eu","headline":"Ohio’s finest: Eight biotech companies leading the way","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNN0VSZUJTamItN2I2Y1pSVV9LUFBiRlNrajFEeGpodWtObHh2b3R3MUdleWU3a1dhQUdLMi1GcVJzdUh6QVVoRWJBMU5DN0FRcHc1MFhtMWRQdWU4aHdRYjY5MmNHTDQxYnpUcXZvV19uM3JXM0hXSkxSRTFMQkdDSGtOM0VISUNNb1BTd0NNRElTU1BoNlBWbURPQ2RTR3MwNjFlZDF3ZFdCRDhmQzJ6NDkyT1lsNW8xdElsNXctNXFjS1dlX0l3azNYTzZzbTlJTGIyQg?oc=5","date":"2024-01-08","type":"pipeline","source":"BioPharma APAC","summary":"Clarametyx Biosciences Secures $33M in Series A Funding for Anti-Biofilm Biologics Development - BioPharma APAC","headline":"Clarametyx Biosciences Secures $33M in Series A Funding for Anti-Biofilm Biologics Development","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}